Current ncd data of following diseases hypertension, diabetes, obesity and cancer .
Searching the Web
global NCD data 2024 2025 hypertension diabetes obesity cancer prevalence statistics
Searching the Web
WHO noncommunicable diseases 2025 statistics hypertension diabetes obesity cancer global burden
Reading Web Page
https://www.thelancet.com/journals/langlo/article/PIIS2214-1…
Searching the Web
global hypertension diabetes obesity cancer statistics 2025 WHO prevalence numbers
Reading Web Page
https://www.who.int/news-room/fact-sheets/detail/noncommunic…
Searching PubMed
noncommunicable diseases global burden hypertension diabetes obesity cancer 2024
Reading Web Page
https://www.who.int/news-room/fact-sheets/detail/diabetes
Here is the current global NCD data for all four diseases, sourced directly from the latest WHO fact sheets (2024-2026):
Current Global NCD Data (2024-2026)
1. Hypertension
(WHO Fact Sheet, updated September 2025)
| Metric | Figure |
|---|---|
| Adults with hypertension (aged 30-79) | 1.4 billion (2024) |
| Prevalence in this age group | 33% (1 in 3 adults) |
| Unaware of their condition | ~600 million (44%) |
| Diagnosed and on treatment | ~630 million (44%) |
| Controlled hypertension | ~320 million (23%) |
| Growth since 1990 | Doubled from 650 million |
| Highest regional prevalence | WHO Eastern Mediterranean Region (38%) |
| Lowest regional prevalence | WHO Western Pacific Region (29%) |
| NCD death attribution | 25% of global NCD deaths (largest metabolic risk factor) |
Key point: Two-thirds of adults with hypertension live in low- and middle-income countries (LMICs). The rise is driven mainly by aging populations in LMICs.
2. Diabetes
(WHO Fact Sheet, updated November 2024)
| Metric | Figure |
|---|---|
| People living with diabetes (2022) | 830 million |
| Adults prevalence (2022) | 14% of all adults 18+ (up from 7% in 1990) |
| Not on medication (2022) | >50% of adults 30+ with diabetes |
| Direct deaths (2021) | 1.6 million |
| Total diabetes-related deaths (2021) | >2 million (including kidney disease deaths) |
| Cardiovascular deaths due to high blood glucose | ~11% |
| Deaths before age 70 | 47% of all diabetes deaths |
Key point: Cases have quadrupled since 1990. Treatment coverage is starkly lower in LMICs, where prevalence is now rising faster than in high-income countries. Source: WHO Diabetes Fact Sheet.
3. Obesity
(WHO Fact Sheet, updated December 2025)
| Metric | Figure |
|---|---|
| Adults living with obesity (2022) | 890 million |
| Adults who are overweight (2022) | 2.5 billion |
| Adults overweight prevalence (2022) | 43%; obese: 16% (1 in 8 worldwide) |
| Children under 5 overweight (2024) | 35 million |
| Children/adolescents 5-19 overweight (2022) | 390 million (20% prevalence, up from 8% in 1990) |
| Adolescent obesity increase since 1990 | Quadrupled |
| Adult obesity increase since 1990 | More than doubled |
Key point: Once considered a high-income problem, obesity is now rising sharply in LMICs. In Africa, childhood overweight increased ~12% since 2000. WHO issued a global guideline on GLP-1 medicines (e.g., semaglutide) for obesity treatment in December 2025. Source: WHO Obesity Fact Sheet.
4. Cancer
(WHO Fact Sheet, updated July 2026)
| Metric | Figure |
|---|---|
| Global cancer deaths (2024) | ~10 million (nearly 1 in 6 of all deaths) |
| Most common cancer (new cases, 2024) | Lung (2.6 million), Breast (2.4 million), Colorectal (2.0 million), Prostate (1.5 million), Stomach (1.0 million) |
| Most deadly cancer (2024) | Lung (1.86 million deaths), Colorectal (918,000), Liver (732,000), Breast (694,000), Stomach (642,000) |
| Children/adolescents newly diagnosed/year | ~400,000 |
| Attributed to modifiable risk factors | Nearly 25% (tobacco, alcohol, obesity, poor diet, inactivity) |
| Infection-attributed cancers | ~30% of cancers in LMICs (HPV, HBV, HCV, H. pylori) |
Key point: Lung cancer remains the top killer. Cervical cancer is the most common cancer among women in 26 countries, mostly in sub-Saharan Africa. Source: WHO Cancer Fact Sheet.
NCD Burden at a Glance
- NCDs account for ~74% of all global deaths (approx. 41 million/year).
- Elevated blood pressure is the #1 metabolic risk factor for NCD deaths globally.
- 82% of premature NCD deaths (before age 70) occur in LMICs.
- The global NCD DALY burden rose from 1.45 billion in 2010 to 1.80 billion in 2023 (GBD 2025, The Lancet).
- All four conditions share common risk factors: unhealthy diet, physical inactivity, tobacco, alcohol, and air pollution.
Sources: WHO Hypertension Fact Sheet (Sep 2025), WHO Diabetes Fact Sheet (Nov 2024), WHO Obesity Fact Sheet (Dec 2025), WHO Cancer Fact Sheet (Jul 2026), GBD 2021/2025 data.
Current ncd data of following diseases hypertension, diabetes, obesity and cancer .
Searching the Web
WHO global NCD data hypertension diabetes obesity cancer 2025 2026 statistics prevalence deaths
Searching the Web
global cancer statistics 2025 2026 GLOBOCAN new cases deaths
Reading Web Page
https://www.who.int/news-room/fact-sheets/detail/noncommunic…
Reading Web Page
https://www.who.int/news-room/fact-sheets/detail/obesity-and…
Here is the current global NCD data for all four diseases, drawn from the latest WHO fact sheets (updated 2024-2026) and peer-reviewed GBD data.
🌍 Current Global NCD Data — 2024/2025/2026
Overall NCD burden: NCDs cause ~41 million deaths per year - nearly 74% of all global deaths. About 18 million premature NCD deaths occur before age 70, and 82% of those happen in low- and middle-income countries (LMICs).
🔴 1. Hypertension
WHO Fact Sheet — updated September 2025
| Indicator | Data |
|---|---|
| Global cases (adults 30-79) | 1.4 billion (2024) |
| Prevalence | 33% of adults aged 30-79 (1 in 3) |
| Unaware of their condition | ~600 million (44%) |
| Diagnosed & on treatment | ~630 million (44%) |
| Controlled hypertension | ~320 million (23%) |
| Growth since 1990 | Doubled from 650 million |
| Highest regional prevalence | WHO Eastern Mediterranean: 38% |
| Lowest regional prevalence | WHO Western Pacific: 29% |
| Share of global NCD deaths | #1 metabolic risk factor - attributed to 25% of NCD deaths |
| LMIC burden | Two-thirds of all hypertension cases are in LMICs |
Trend: The sharp rise is driven primarily by aging populations in LMICs. Despite 44% being on treatment, only 23% have blood pressure under control - a major care gap.
🟠 2. Diabetes
WHO Fact Sheet — updated November 2024
| Indicator | Data |
|---|---|
| People living with diabetes (2022) | 830 million |
| Adult prevalence (2022) | 14% of adults 18+ (was 7% in 1990) |
| Growth since 1990 | Cases quadrupled (from 200 million in 1990) |
| Not on medication (2022) | >50% of adults 30+ with diabetes |
| Direct deaths (2021) | 1.6 million |
| Total diabetes-related deaths | >2 million (includes 530,000 kidney disease deaths) |
| Cardiovascular deaths linked to high glucose | ~11% of all CV deaths |
| Premature deaths (before age 70) | 47% of all diabetes deaths |
| Fastest growth region | LMICs - rising faster than high-income countries |
Trend: WHO issued an urgent alert in November 2024 that global diabetes cases have increased four-fold over past decades. Mortality rates have been rising since 2000, in contrast to declining probability of dying from other major NCDs. Source: WHO Diabetes Fact Sheet.
🟡 3. Obesity
WHO Fact Sheet — updated December 2025
| Indicator | Data |
|---|---|
| Adults living with obesity (2022) | 890 million (1 in 8 people globally) |
| Adults overweight or obese (2022) | 2.5 billion (43% of all adults) |
| Adult obesity prevalence (2022) | 16% |
| Adult obesity growth since 1990 | More than doubled |
| Children under 5 overweight (2024) | 35 million |
| Children & adolescents 5-19 overweight (2022) | 390 million (20%, up from 8% in 1990) |
| Adolescent obesity growth since 1990 | Quadrupled |
| African children under 5 (overweight trend) | +12.1% since 2000 |
| Asia share of childhood obesity | Almost half of overweight children under 5 |
Trend: Once a high-income country problem, obesity is now surging in LMICs. In December 2025, WHO issued a global guideline on GLP-1 receptor agonist medicines (e.g., semaglutide) for treating obesity. Obesity is a key driver for diabetes, cardiovascular disease, and several cancers. Source: WHO Obesity Fact Sheet.
🟣 4. Cancer
WHO Fact Sheet — updated July 3, 2026 (GLOBOCAN/IARC data)
| Indicator | Data |
|---|---|
| Global cancer deaths (2024) | ~10 million (nearly 1 in 6 of all deaths) |
| Children/adolescents newly diagnosed/year | ~400,000 |
| Deaths due to modifiable risk factors | ~25% (tobacco, alcohol, obesity, poor diet, inactivity) |
| Infection-attributed cancers (LMICs) | ~30% (HPV, HBV, HCV, H. pylori) |
Most common cancers by new cases (2024):
| Rank | Cancer | New Cases |
|---|---|---|
| 1 | Lung | 2.6 million |
| 2 | Breast | 2.4 million |
| 3 | Colorectal | 2.0 million |
| 4 | Prostate | 1.5 million |
| 5 | Skin (non-melanoma) | 1.1 million |
| 6 | Stomach | 1.0 million |
Top causes of cancer death (2024):
| Rank | Cancer | Deaths |
|---|---|---|
| 1 | Lung | 1,860,000 |
| 2 | Colorectal | 918,000 |
| 3 | Liver | 732,000 |
| 4 | Breast | 694,000 |
| 5 | Stomach | 642,000 |
Trend: Cardiovascular diseases projected to account for 86.1% of NCD deaths by 2050, but cancer incidence is rising steadily, particularly in high-income regions. Cervical cancer remains the most common cancer in women in 26 countries, mainly in sub-Saharan Africa. Source: WHO Cancer Fact Sheet.
📊 Side-by-Side Summary
| Disease | People Affected | Annual Deaths | Key Trend |
|---|---|---|---|
| Hypertension | 1.4 billion (2024) | Contributes to 25% of NCD deaths | Doubled since 1990 |
| Diabetes | 830 million (2022) | >2 million directly | Quadrupled since 1990 |
| Obesity | 890 million obese; 2.5 billion overweight (2022) | Drives multiple NCD deaths | Adult obesity doubled; adolescent obesity quadrupled since 1990 |
| Cancer | ~20 million new cases/year | ~10 million (2024) | Steadily rising; lung cancer #1 killer |
Common shared risk factors across all four: unhealthy diet, physical inactivity, tobacco use, alcohol consumption, and air pollution. Tackling these upstream determinants remains the most cost-effective global intervention.
This is a shared conversation. Sign in to Orris to start your own chat.